Skip to content
Clinical Trials – home
LuxembourgBack to Luxembourg

Clinical trials in Luxembourg – page 7

153 clinical trials in Luxembourg, Luxembourg across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Luxembourg at a glance
153
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

153 trials in Luxembourg

Open in trial search

Pneumonia+1

Not yet recruiting

Early Use of Dexamethasone versus Sodium Chloride Placebo in Patients with Severe Influenza-Induced Acute Hypoxemic Respiratory Failure (Phase III Randomized Trial)

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Centre Hospital Region Metz Thionville

Endometrial cancer

Not yet recruiting

Study of GSK5733584 versus paclitaxel or doxorubicin in patients with advanced or recurrent endometrial cancer after platinum‑based chemotherapy and immunotherapy

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:GSK5733584
  • Sponsor:Glaxosmithkline Research & Development Limited

Testing continuous versus intermittent treatment with cetuximab, fluorouracil, folinic acid, and irinotecan in patients with newly diagnosed metastatic colorectal cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Charite Universitaetsmedizin Berlin KöR

Type 2 diabetes mellitus

Not yet recruiting

Comparison of weekly insulin icodec versus daily basal insulin in adults with type 2 diabetes who have not used insulin before

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Insulin degludec
  • Sponsor:Novo Nordisk A/S

Acne

Not yet recruiting

Study on the Effectiveness and Safety of Clindamycin and Tretinoin Gel for Patients with Papulopustular Acne

Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Clindamycin
  • Sponsor:Dermapharm AG

Insomnia

Not yet recruiting

Study on the Effectiveness and Safety of AV-EC2023 Tablets for Adults with Insomnia

Investigational
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Av-Ec2023
  • Sponsor:A.Vogel AG

Breast cancer

Not yet recruiting

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Eli Lilly & Co.

Study on the Effectiveness of Paclitaxel, Carboplatin, and Durvalumab for Patients with Extensive Stage Small Cell Lung Cancer

Registered drugNo placebo
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Intergroupe Francophone De Cancerologie Thoracique

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Dulaglutide
  • Sponsor:Eli Lilly & Co.

Study of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Florbetaben (18F)
  • Sponsor:F. Hoffmann-La Roche AG

A study testing trontinemab compared to placebo in patients with early Alzheimer's disease including mild cognitive impairment and mild dementia

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Florbetaben (18F)
  • Sponsor:F. Hoffmann-La Roche AG

Dermatitis atopic

Not recruiting

Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis

Investigational
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Other cities in Luxembourg

The busiest research cities in the country

All 2 cities in Luxembourg

Clinical research in Luxembourg

What the registry says about research in the country

01 Orthopedic Research

Innovative studies focusing on bone reconstruction and healing, particularly examining advanced treatment options for challenging limb conditions and fractures.

  • Lower limb nonunion treatment
  • Lumbar spondylolisthesis therapy
  • Distal radius fracture management

Research emphasizes novel osteogenic implants and their long-term safety profiles in various skeletal conditions.

02 Neurology Studies

Ground-breaking research in Parkinson's disease treatment, investigating new therapeutic approaches for early-stage patients.

  • Motor progression assessment
  • Novel drug interventions
  • Early-stage disease management

Trials focus on evaluating innovative treatments to slow disease progression and improve patient outcomes.

03 Oncology Research

Advanced studies in Small Cell Lung Cancer treatment, exploring combination therapies for extensive disease states.

  • First-line therapy evaluation
  • Immunotherapy combinations
  • Systemic treatment approaches

Research aims to enhance treatment efficacy through innovative drug combinations.

04 Infectious Disease Studies

Comprehensive research on COVID-19 treatments, investigating multiple therapeutic approaches for varying disease severities.

  • Moderate COVID-19 management
  • Severe disease intervention
  • Immunocompromised patient care

Trials evaluate novel therapeutic agents and their efficacy in different patient populations.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.